Investing.com - AstraZeneca (NASDAQ:AZN) reported on Friday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
AstraZeneca announced earnings per share of $1.08 on revenue of $9.87B. Analysts polled by Investing.com anticipated EPS of $1.25 on revenue of $9.49B.
AstraZeneca shares are up 14% from the beginning of the year, still down 4.95% from its 52 week high of $9,523.00 set on November 5. They are under-performing the Euro Stoxx 50 which is up 22.88% from the start of the year.
AstraZeneca shares lost 4.14% in intra-day trade following the report.
AstraZeneca follows other major Healthcare sector earnings this month
AstraZeneca's report follows an earnings beat by GlaxoSmithKline on October 27, who reported EPS of $0.366 on revenue of $9.08B, compared to forecasts EPS of $0.2863 on revenue of $8.69B.
Mediclinic Int had missed expectations on Thursday with second quarter EPS of $0.09 on revenue of $1.58B, compared to forecast for EPS of $0.44 on revenue of $1,380M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar